Sermorelin Half-Life: How Long It Stays in Your System
How long Sermorelin stays in the body, how that shapes dosing frequency, and what is known about drug testing.
- Half-life
- Not found
- No published half-life found (PubMed search, 11 Oct 2026)
- Dosing interval
- Varies by study
- as used in studies
- WADA
- Prohibited (S2.2.4)
- In and out of competition
- Detection window
- 2 findings
- from anti-doping studies, below
Sermorelin half-life
Half-life: no published half-life found (PubMed search, 11 Oct 2026). A half-life depends on the route (under the skin, into a vein, by mouth or nasal spray), so we report it per route with the study it came from.
What half-life means
Half-life is the time it takes for the amount of a drug in the blood to fall by half. After one half-life, about 50% is left; after two, about 25%; after four to five, only a few percent remain.
- A long half-life lets a drug be dosed less often, for example once a week.
- A short half-life means levels rise and fall quickly, which is why some peptides are given daily or more often.
- Effects can outlast blood levels, so half-life alone does not tell you how long a drug works.
What it means for dosing frequency
Dosing intervals used in published studies of Sermorelin:
- twice daily, subcutaneous (Human RCT; The Journal of clinical endocrinology and metabolism 1992, PMID 1379256)
- three times daily, not stated (Human observational; American journal of men's health 2017, PMID 28830317)
- nightly self-injection, subcutaneous (Human uncontrolled trial; Metabolism: clinical and experimental 1997, PMID 9005976)
- once daily at bedtime, subcutaneous (Human uncontrolled trial; The Journal of clinical endocrinology and metabolism 1996, PMID 8772599)
Changing the interval changes how much drug builds up between doses, so it is not a free choice.
Drug tests and sport
Prohibited by WADA (S2.2.4)Sermorelin is named as a GHRH analogue in S2.2.4 (growth hormone releasing factors), prohibited at all times.
Detection findings from anti-doping analytical studies:
- A urine assay detects CJC-1295 and other GHRH analogues at very low concentrations. · PMID 35298973
- Labs expect GHRH analogues like CJC-1295 to be hard to find because of tiny urine concentrations; the study reports no detections in routine anti-doping samples. · PMID 34665524
Tested athletes should treat it as prohibited (s2.2.4) at all times.
Laboratory half-lives of the sequence sermorelin comes from
In porcine plasma in vitro, GRF(1-29)-NH2 broke down with a t1/2 of 13 min.[12]
Substituting Gly15 with Ala15 slightly prolonged that plasma half-life, to 17 min.[12]
A separate rat study of GRF amide gave apparent half-lives of 18 min in rat serum and 13 min in liver homogenate.[13]
No human sermorelin figure is cached
The only FDA record is Geref, marked discontinued, so there is no marketed label whose pharmacokinetics section could be quoted.[14]
WADA's prohibited list names sermorelin as an example of a GHRH analogue.[1]
Common questions
How long does Sermorelin stay in your system?
We found no published half-life for Sermorelin (PubMed search, 11 Oct 2026). As a rule, most of a dose is cleared after about four to five half-lives.
What is the half-life of sermorelin?
No human value is cached; the nearest figure is 13 min for GRF(1-29)-NH2 in porcine plasma in vitro.[12]
Is Sermorelin on the WADA prohibited list?
Yes. Prohibited by WADA (S2.2.4).
Does sermorelin show up on a drug test?
Sermorelin is a named substance on WADA's prohibited list. The cached sources say nothing about workplace drug panels.[1]
Is sermorelin on the WADA list?
Yes. WADA's list names sermorelin as a GHRH analogue.[1]
More on Sermorelin
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.Journal of pharmaceutical and biomedical analysis · 2022PMID 35298973Accessed 2 Oct 2026
- 3Advances in the detection of growth hormone releasing hormone synthetic analogs.Drug testing and analysis · 2021PMID 34665524Accessed 2 Oct 2026
- 4Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.The Journal of clinical endocrinology and metabolism · 1992PMID 1379256Accessed 2 Oct 2026
- 5Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.American journal of men's health · 2017PMID 28830317Accessed 2 Oct 2026
- 6Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.Metabolism: clinical and experimental · 1997PMID 9005976Accessed 2 Oct 2026
- 7Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.The Journal of clinical endocrinology and metabolism · 1996PMID 8772599Accessed 2 Oct 2026
- 8PubMed search: (sermorelin[tiab] OR Geref[tiab]) (34 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: (sermorelin[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab] OR "GHRH 1-29"[tiab]) AND (elderly[tiab] OR aging[tiab] OR "older adults"[tiab] OR adults[tiab]) AND (treatment[tiab] OR therapy[tiab] OR administration[tiab]) (15 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: (sermorelin[tiab] OR Geref[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: (sermorelin[tiab] OR Geref[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 12In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1991PMID 1826667Accessed 5 Oct 2026
- 13Catabolism of rat growth hormone-releasing factor(1-29) amide in rat serum and liver.Peptides · 1992PMID 1437711Accessed 5 Oct 2026
- 14Drugs@FDA (openFDA) search: active ingredient "sermorelin"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
Found an error? Report a correction.